Stock FRBN FORN EUROPAR
Add to a list
To use this feature you must be a member
Log inSign up

All News FORN EUROPAR

Equities

FRBN

KYG3619H1020

Delayed Nasdaq
Other stock markets
 20:07:36 05/07/2024 BST 		5-day change 1st Jan Change
9 USD +0.11% Intraday chart for FORN EUROPAR +12.38% -58.52%
2023 EnGene, Inc. completed the acquisition of Forbion European Acquisition Corp. from a group of shareholders in a reverse merger transaction. CI
2023 Forbion European Acquisition Corp.(NasdaqGM:FRBN) dropped from NASDAQ Composite Index CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
EnGene, Inc. completed the acquisition of Forbion European Acquisition Corp. from a group of shareholders in a reverse merger transaction.
CI
Forbion European Acquisition Corp.(NasdaqGM:FRBN) dropped from NASDAQ Composite Index
CI
Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting
MT
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Wall Street Set to Open Higher Friday; Core Inflation Rises 0.3% Matching Forecast
MT
Top Premarket Decliners
MT
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding
CI
Forbion European Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding from Forbion Growth Sponsor Feac I B.V.
CI
EnGene, Inc. and Forbion European Acquisition Corp. ("FEAC", Nasdaq: FRBN) Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies - Form 8-K
PU
Forbion European Acquisition Corp. entered into a business combination agreement to acquire enGene, Inc from shareholders.
CI
Forbion European Acquisition Corp. announced that it has received $56.891682 million in funding from a group of investors
CI
Forbion European Acquisition Corp. announced that it received $56.891682 million in funding from enGene Holdings, and other investors
CI
Forbion European Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Forbion European Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Forbion European Acquisition Corp. Auditor Raises 'Going Concern' Doubt
CI
Forbion European Acquisition Corp. announced that it expects to receive $0.9 million in funding
CI
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Certain Class B Ordinary Shares of Forbion European Acquisition Corp. are subject to a Lock-Up Agreement Ending on 8-JUN-2022.
CI
Forbion European Acquisition Corp.(NasdaqGM:FRBN) added to NASDAQ Composite Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FRBN Stock
  4. News FORN EUROPAR